At the completion of the activity viewers will be able to;

Identify the differences between billing under Medicare Part B for medical supplies and transplant medications and those similar billings under Medicare Part D.
Explain the enrollment procedures, annual billing requirements and requirements and revalidation procedures regarding Medicare Part B suppliers.
Describe the effect of the Affordable Care Act on pharmacy compliance with integrity initiatives and understand requirements of Medicare Part D fraud, waste and abuse annual training as well as similar requirements for participation in the New York State Medicaid program.
Explain how, why and where to check for excluded and disqualified prescribers, and potential employees due to various violations of both criminal and health care laws and related regulations
The presentation will cover the requirements place by the Drug Enforcement Administration (DEA) through their Diversion Control Division (Diversion) on wholesalers of controlled substances.
After the presentation, the participants will be familiar with the role of DEA and their recent changes and actions for controlled substances.
State the role of DEA Diversion personnel who enforce pharmaceutical federal laws under the Controlled Substances Act and DEA regulations.
Describe the recent DEA Settlement Agreement signed on December 23, 2021, by the major three wholesale of controlled substance distributors.
List wholesalers of controlled substances DEA Due Diligence requirements for controlled substance customers.
State the requirements of the wholesalers of controlled substances on their pharmacy customers such as providing controlled substance records and dispensing information.